ÂÜÀòÂÒÂ×

Dr. Christiane Honisch as Senior Vice President of the Diagnostics Devision (Evognostics) at Evotec responsible for building novel patient stratifications based on omics technologies and machine learning along with Evotec’s drug discovery target identification.

She is an independent member of the company board of directors at PathoQuest, a genomic expert dedicated to the microbiology testing market.

With over 20 years of experience in developing assays and cutting-edge technology like next-generation sequencing and mass spectrometry for the Life Science and Diagnostics industry, she joined Evotec from Eppendorf AG, where she was Head of Global Business Intelligence and Development.

Prior to Eppendorf Christiane was Director of Microbiology Markets at Illumina, Inc. in San Diego, CA, the USA, and Director of Infectious Disease Research at Roche Molecular Diagnostics in San Francisco, CA, USA. Her career started as a key individual in the development of nucleic acid mass spectrometry for infectious diseases, oncology, and prenatal diagnostics at Sequenom, Inc., San Diego, CA, USA.